Background:
The Kidney Failure Risk Equation (KFRE) is recommended in international guidelines for estimating the risk of kidney failure in patients with chronic kidney disease (CKD). The prognostic relevance of the KFRE has not been described in patients with heart failure and mildly reduced or preserved ejection f...
R. Ono, K. Docherty, A. Henderson et al.· Circulation· 0 citations
Early detection of congestion among adults with heart failure and preserved ejection fraction (HFpEF) is critical to optimize therapy prior to overt decompensation, yet traditional tools are insensitive. We sought to examine the association between B-lines on lung ultrasound (LUS) in ambulatory adults with HFpEF...
Elke Platz, K. McDowell, Deepak K. Gupta et al.· European Heart Journal Open· 0 citations
Obesity is associated with lower natriuretic peptide concentrations, potentially reducing the diagnostic accuracy of N-terminal pro–B-type natriuretic peptide (NT-proBNP) for heart failure with preserved ejection fraction (HFpEF). Several body mass index (BMI)–adjusted NT-proBNP thresholds have been proposed, but...
R. Ono, R. Campbell, A. Henderson et al.· European Heart Journal· 0 citations
Many patients with suspected heart failure (HF) experience long waits for echocardiography, despite risk-stratification using natriuretic peptides (NP). Prioritising echocardiography in those who are likely to have HF with reduced ejection fraction (HFrEF) would be of value in many healthcare settings and to pati...
U. Razzaq, K. Docherty, A. Morton et al.· European Heart Journal· 0 citations
BACKGROUND
Patients hospitalized for heart failure often require prolonged intravenous diuretic therapy, contributing to costs and risks associated with inpatient care.
OBJECTIVES
We evaluated whether an early discharge strategy using subcutaneous furosemide delivered via a wearable minipump could increase days alive...
Ross T. Campbell, J. Osmanska, K. Docherty et al.· Journal of the American Coll...· 1 citation
The sodium-glucose cotransporter 2 inhibitor empagliflozin reduces left ventricular (LV) volumes in heart failure with reduced ejection fraction (HFrEF). Whether this effect is additive to optimal background guideline-recommended therapy is unknown.
To evaluate the effects of empagliflozin according to key...
M. Lee, C. Berry, R. Campbell et al.· European Heart Journal· 0 citations
BACKGROUND
The HFpEF-ABA score is a simple diagnostic tool developed to estimate the probability of heart failure with preserved ejection fraction (HFpEF) using age, body mass index, and history of atrial fibrillation.
OBJECTIVES
This study aims to evaluate the HFpEF-ABA score in patients with confirmed heart failure...
R. Ono, K. Docherty, A. Henderson et al.· JACC. Heart failure· 0 citations
BACKGROUND
Heart failure (HF) is a common cardiovascular complication of diabetes. Early identification of unrecognized HF enables initiation of disease-modifying therapies. International diabetes and HF clinical practice guidelines are inconsistent with respect to recommendations for screening for HF in people with di...
D. Taylor-Sweet, M. Petrie, Gemma Mckinley et al.· Journal of the American Coll...· 1 citation
BACKGROUND AND AIMS
N-terminal pro-B-type natriuretic peptide (NT-proBNP) is recommended to guide echocardiography referral in community-based patients with suspected heart failure (HF), but diagnostic performance is influenced by individual characteristics including age, ethnicity, kidney function, cardiac rhythm, and...
K. Docherty, B. Heywood, L. Anderson et al.· European Heart Journal· 0 citations
Recurrent MI is associated with a higher risk of all-cause mortality, hospitalization for heart failure, HHF, and further recurrent MI compared with first-time MI.
D. M. Christensen, C. Garred, M. Malmborg et al.· American Heart Journal· 0 citations
A prediction model is developed to estimate the short-term treatment effects of combination medical therapy on systolic blood pressure (SBP), diastolic BP, estimated glomerular filtration rate (eGFR) and serum potassium and individualized estimates of the expected treatment effect are provided.
Nelson Wang, B. Claggett, M. Pfeffer et al.· Nature Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.